Media & events
News
-- Lyndra Therapeutics announced that Fujifilm has joined the company’s Series B raise, bringing the total round to $60 million --
February 11, 2019
-- Lyndra Therapeutics, which is moving toward making daily pills a thing of the past, today announced it has raised $55 million in Series B financing, funds it will use for Phase II clinical trials, expansion of its Phase I pipeline and manufacturing scale-up --
January 29, 2019
-- Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for intellectual property (IP) related to Lyndra’s ultra-long-acting oral drug delivery system--
December 10, 2018
--Study results show novel drug delivery system achieves long-lasting levels of three highly-potent antiretrovirals in the circulation in an animal model--
--Company developing long-acting oral formulations of HIV therapies to address viral resistance and improve therapeutic success--
January 8, 2018
--Companies will collaborate to create products dosed once-weekly for the treatment of Alzheimer’s disease--
September 7, 2017
Research by Robert Langer, Giovanni Traverso, Andrew Bellinger and Others Published in Science Translational Medicine
--Novel technology can be applied in fight against malaria and other diseases requiring oral sustained release, long-term drug dosage--
November 16, 2016
Publications
Changing the Pill: Developments Toward the Promise of an Ultra-Long-Acting Gastroretentive Dosage Form
Expert Opinion on Drug Delivery, November 13, 2018
Development of an Oral Once-Weekly Drug Delivery System for HIV Antiretroviral Therapy
Nature Communications, January 09, 2018
Lyndra White Paper on Adherence to Medication
October 03, 2016
awards
Amy Schulman at #TEDMED2017 in The Hive
TEDMED Hive Talk, November 1-3, 2017
Xconomy Newcomer Award Winner Amy Schulman on Boston Biotech Life
Xconomy, October 3, 2016
events
How to Advocate for Yourself #WESTadvocate
Lyndra Therapeutics, January 30, 2019
Press Coverage
- Aiming to change the way people take medicine, Lyndra Therapeutics raises $55 million (TechCrunch, January 29, 2019)
- Lyndra Therapeutics raises $55 million from Gilead and Gates (STAT, January 29, 2019)
- Gilead, Gates Foundation join Watertown biotech's $55M financing round (Boston Business Journal, January 29, 2019)
- Gilead, Gates Foundation Join Lyndra’s $55M Funding for Phase 2 Tests (Xconomy, January 29, 2019)
- Watertown biotech plans first clinical trial of weeklong schizophrenia drug (BBJ, November 15, 2018)
- Watertown biotech plans first clinical trial of weeklong schizophrenia drug (BBJ, November 15, 2018)
- Sick of a daily pill? A Boston biotech wants to make a daily Alzheimer’s drug last for a week — and they’re working on more (STAT, November 15, 2018)
- A Gates Foundation-Backed Startup Wants to Make Daily Pills a Thing of the Past (Business Insider, February 02, 2018)
- Drug Capsule May Allow Weekly HIV Treatment (European Pharmaceutical Review, January 09, 2018)
- Swallowing A 'Mini-Pillbox' Could Change The Way HIV Drugs Are Delivered (NPR, January 09, 2018)
- Lyndra Announces Feasibility Study of Oral Once-Weekly HIV Drug (MD Magazine, January 09, 2018)
- Lyndra Announces Feasibility Study of Oral Once-Weekly HIV Drug (Daily Mail, January 09, 2018)
- Once-a-Week Pill for HIV (BBC, January 09, 2018)
- Alzheimer's: Treating with a Daily Pill in the Future? (Fox Business News, September 07, 2017)
- Watertown’s Lyndra Strikes Alzheimer’s Pact with Allergan Worth up to $105M (Boston Business Journal, September 07, 2017)
- Lyndra Raises $23M in Series A to Progress Ultra-Long-Acting Oral Drug Delivery Tech (Genetic Engineering & Biotechnology News, April 13, 2017)
- Lyndra’s Long-Acting Drug Delivery Technology Lands $23M Investment (Xconomy Boston, April 13, 2017)
- Watertown's Lyndra Nabs $23M to Bankroll Long-Lasting Pill Tech (Boston Business Journal, April 13, 2017)
- How a Small Watertown Biotech is Trying to Make Oral Drugs Last Longer (Boston Business Journal, November 16, 2016)
- Long-Lasting Pill to Replace Daily Dose (The Times, November 17, 2016)
- 'Ultra-Long-Acting' Pill Delivers Malaria Drug for 14 Days (FierceBiotech, November 16, 2016)
- Long-Lasting Pill that Releases Malaria Drug for Two Weeks a 'Game-Changer' (The Guardian, November 16, 2016)